PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Molecular mechanisms of disease pathophysiology: Journal of Pharmaceutical Analysis articles provide novel insights

Pre-clinical studies exploring the molecular mechanisms of neurological and cardiovascular disease processes could pave the way for novel therapeutic strategies

Molecular mechanisms of disease pathophysiology: Journal of Pharmaceutical Analysis articles provide novel insights
2023-03-28
(Press-News.org) The burden of cardiovascular, metabolic, and neurological diseases (including ischemic heart disease, stroke, diabetes, and Parkinson’s disease) is particularly high, and these conditions affect millions around the world annually. In order to develop effective treatment strategies against these diseases, it is important to delineate the cellular and molecular pathways that contribute to their development. Three pre-clinical studies published in Volume 13 Issue 2 of Journal of Pharmaceutical Analysis have done just that.

The first study, published online on December 5, 2022, focused on myocardial infarction (MI), better known as a heart attack. Given that the repair of damaged heart tissue following MI is crucial for maintaining cardiac function and prolonging patient survival, the study explored the mechanisms underlying this process. It focused on elucidating the role of a post-translational modification called SUMOylation and the response of cardiac cells to the lack of SUMO1, a key protein involved in this modification. The study revealed that mutant mice who lack SUMO1 show aggravated systolic dysfunction and infarct size after MI. Single-nucleus RNA sequencing and in vitro studies were conducted in three cell types: cardiomyocytes (heart muscle cells), fibroblasts (which provide collagen and connective tissue for heart cells), and endothelial cells (which line the blood vessels). The authors sum up their findings: “The findings revealed that SUMO1 overexpression and deletion in different cell types have different effects on cardiac recovery following MI. However, its cardiomyocyte-specific overexpression can have cardiac benefits.” Hence, modulating SUMO1 expression in different heart cell types could enable the treatment of MI.

Made available online on November 21, 2022, the second study examined the mechanisms underlying a link between diabetes and Parkinson’s disease. One key finding was that high glucose levels in the brain microenvironment contributed to the increased risk of Parkinson's disease in patients with diabetes. Interestingly, the researchers found that high glucose levels enhance the neurotoxic effects of the neurotoxin 6-hydroxydopamine (6-OHDA) in motor neurons. Metabolomic analysis revealed that high glucose levels impair neuronal energy generation pathways, promoting mitochondrial loss and neuronal death. These effects are mediated by a protein called pyruvate kinase M2 (PKM2), which is involved in glucose metabolism. Interestingly, blocking this protein could prevent neuronal damage and reduce the risk of Parkinson's disease in diabetic rats. “Therefore,” one author says, “the targeted inhibition of PKM2 could offer a new tool for preventing the development of Parkinson's disease in people with diabetes.”

The final study explored the potential of a potent antioxidant, celastrol, in mitigating oxidative damage after ischemic stroke. The results of this study, which was published online on January 7, 2023, attested to the potential of celastrol in exerting antioxidative effects on astrocytes, a type of brain cell, after ischemic stroke. They showed that celastrol treatment leads to an increase in the expression of a protein called Nrf2 by targeting Nedd4, an enzyme. Liquid chromatography-tandem mass spectrometry revealed that celastrol directly bound to Nedd4, releasing Nrf2 from Nedd4 in astrocytes. Celastrol also blocked the Nedd4-induced increase in astrocytic reactive oxygen species following ischemic injury. Accordingly, celastrol inhibited oxidative stress and astrocyte activation, preventing damage to nerve processes (axons) and apoptosis of neurons. The authors of this study believe that “celastrol could be a potential therapeutic agent for stroke.”

The findings from this series of studies open up new therapeutic doors, and provide hope for the development of better disease management strategies

 

***

 

Reference

Authors: Zhihao Liu a, b, Xiaozhi Liu c, Li Liu a, b, Ying Wang c, Jie Zheng c, Lan Li b, d, Sheng Li b, Han Zhang b, d, Jingyu Ni b, d, Chuanrui Ma a, Xiumei Gao b, d, Xiyun Bian c, and Guanwei Fan a, b, d

DOI: https://doi.org/10.1016/j.jpha.2022.11.010

Affiliations:

a First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion

b State Key Laboratory of Component-Based Chinese Medicine

c Tianjin Key Laboratory of Epigenetics for Organ Development in Preterm Infants, The Fifth Central Hospital of Tianjin

d Haihe Laboratory of Modern Chinese Medicine 

END


[Attachments] See images for this press release:
Molecular mechanisms of disease pathophysiology: Journal of Pharmaceutical Analysis articles provide novel insights

ELSE PRESS RELEASES FROM THIS DATE:

New study reveals clinical instability predicts psychiatric hospitalization

New study reveals clinical instability predicts psychiatric hospitalization
2023-03-28
NEW YORK — MARCH 28, 2023 – For patients with psychiatric conditions, illness severity and instability are key factors in predicting future risk of hospitalization, according to a new study by Holmusk, a leading behavioral health real-world evidence and data analytics company, that has been published in The Lancet Psychiatry. The study, which was enabled by Holmusk’s NeuroBlu Database, could prove useful across the behavioral health care and research ecosystem, from facilitating early intervention to supporting the development of more targeted treatments. The research was conducted using Holmusk’s NeuroBlu Database, a real-world data source that contains ...

New method for fast, efficient and scalable cloud tomography

New method for fast, efficient and scalable cloud tomography
2023-03-28
How do clouds shape the planet’s future? Clouds are not just fluffy white shapes in the sky. They are vital for regulating the earth’s climate, as they influence the water cycle, atmospheric dynamics and energy balance. However, studying clouds is not easy. One way to do so is to use spaceborne imagers, but these imagers still face challenges of efficiency and scalability. To overcome these limitations, Ido Czerninski and Yoav Y. Schechner from the Viterbi Faculty of Electrical and Computer Engineering at the Technion—Israel Institute of Technology, a partner of CloudCT, have developed an effective inverse rendering framework ...

How to protect the integrity of survey research: 12 recommendations

2023-03-28
Science requires data, and survey research is one important means of gathering it. Surveys provide a scientific way of acquiring information that is used to inform policy decisions, guide political campaigns, clarify the needs of stakeholders, enhance customer service, help society understand itself, and improve the quality of life in the United States. In recent years, concerns have been raised about growing rates of refusal to participate in surveys, as well as about inaccurate forecasts in high-profile ...

Significant disparities in breast cancer care persist, but surgeons can drive change

Significant disparities in breast cancer care persist, but surgeons can drive change
2023-03-28
Key takeaways Inequitable access to breast cancer care: Treatment options for breast cancer are increasing, but many groups still do not have equitable access to preventative services, such as screening mammograms, and new therapies or drugs. Wide spectrum of disparities: Screening, genetic testing, reconstruction, and fertility preservation are four significant areas where disparities exist and where surgeons should maintain awareness. Surgeons can drive change: Surgeons can raise the standard of care at their institutions by improving their understanding of these disparities and advocating for their patients. CHICAGO: Surgeons can play a key role ...

SwRI creates innovative, efficient hydrogen compressor for FCEV refueling stations

SwRI creates innovative, efficient hydrogen compressor for FCEV refueling stations
2023-03-28
SAN ANTONIO — March 28, 2023 - A new hydrogen compressor developed at Southwest Research Institute (SwRI) can improve the efficiency and reliability of hydrogen compression used in the refueling of fuel cell electric vehicles (FCEVs). The SwRI-developed linear motor-driven reciprocating compressor (LMRC) is designed to compress hydrogen as a fuel source for FCEVs and other hydrogen-powered vehicles. Unlike most hydrogen compressors, SwRI’s LMRC is hermetically sealed and has a linear motor design that increases its ...

Europe PMC integrates ROR into its Grant Finder

Europe PMC integrates ROR into its Grant Finder
2023-03-28
Europe PMC, one of the largest providers of high-performance search tools for life sciences literature, has announced that its Grant Finder now incorporates Research Organization Registry (ROR) IDs to help users find active and completed grants awarded by Europe PMC funders. As one of the operating organizations of ROR, Crossref is pleased to jointly announce this news. Integrating ROR IDs into the Europe PMC Grant Finder means that organizational name variations are now aggregated under a single name, which allows people to search for different aliases and receive the same set of results. Europe PMC used the ROR API in conjunction with a manual screening step to match 82% of ...

Pulsed radiofrequency with steroid injection brings sciatica relief

Pulsed radiofrequency with steroid injection brings sciatica relief
2023-03-28
OAK BROOK, Ill. – Researchers found that a minimally invasive procedure combined with epidural steroid injection treatment led to superior pain reduction and disability improvement over one year in patients with sciatica. The results of the study were published in Radiology, a journal of the Radiological Society of North America (RSNA). The combined treatment performed better than steroid injections alone. Sciatica is pain that originates along the sciatic nerve, which extends from the back of the pelvis down the back of the thigh. The sciatic nerve is the largest nerve in the body. Treatments ...

Probe where the protons go to develop better fuel cells

Probe where the protons go to develop better fuel cells
2023-03-28
Fukuoka, Japan—Solid oxide fuel cells, or SOFC, are a type of electrochemical device that generates electricity using hydrogen as fuel, with the only 'waste' product being water. Naturally, as we strive to reduce our carbon output and mitigate the casualties of the climate crisis, both business and academia have taken major interest in the development of SOFCs. In what can potentially accelerate the development of more efficient SOFCs, a research team led by Kyushu University has uncovered the chemical innerworkings of a perovskite-based ...

Could changes in Fed’s interest rates affect pollution and the environment?

Could changes in Fed’s interest rates affect pollution and the environment?
2023-03-28
Can monetary policy such as the United States Federal Reserve raising interest rates affect the environment? According to a new study by Florida Atlantic University’s College of Business, it can.  Using a stylized dynamic aggregate demand-aggregate supply (AD-AS) model, researchers explored the consequences of traditional monetary tools – namely changes in the short-term interest rate – to the environment. Specifically, they looked at how monetary policy impacts CO2 emissions in the short and long run. The AD-AS model conveys several interlocking relationships between the four macroeconomic goals of growth, unemployment, inflation and a sustainable balance ...

For advanced endometrial cancer, chemotherapy plus immunotherapy improves outcomes

2023-03-28
Endometrial cancer, which makes up about 90% of uterine cancers, will be diagnosed in more than 65,000 people in the United States this year. It is the fourth most common cancer in women and is one of the few cancers that is increasing in incidence and mortality. Unfortunately, very few treatments have been developed specifically for endometrial cancer. Now, new research published March 27, 2023, in The New England Journal of Medicine finds adding the immunotherapy drug pembrolizumab (Keytruda®) to standard chemotherapy greatly improves patient outcomes in both patients whose tumors have a genetic alteration leading ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Molecular mechanisms of disease pathophysiology: Journal of Pharmaceutical Analysis articles provide novel insights
Pre-clinical studies exploring the molecular mechanisms of neurological and cardiovascular disease processes could pave the way for novel therapeutic strategies